Ellipticine derivatives interact with muscarinic receptors

This publication has 11 references indexed in Scilit:

• Inhibition of acetylcholinesterase and cholinesterase by ellipticine derivatives
  Biochemical Pharmacology, 1983
• Pharmacokinetics of 2-methyl-9-hydroxyellipticinium acetate (NSC-264137) in cancer patients (phase I study)
  European Journal of Cancer and Clinical Oncology, 1982
• CHARACTERIZATION OF NICOTINE BINDING IN MOUSE-BRAIN AND COMPARISON WITH THE BINDING OF ALPHA-BUNGAROTOXIN AND QUINUCLIDINYL BENZILATE
  1982
• HYDROXY-9-METHYL-2-ELLIPTICINIUM FOR OSSEOUS METASTASES FROM BREAST-CANCER - A 5-YEAR EXPERIENCE
  1982
• ACTIVATION AND BLOCKADE OF CARDIAC MUSCARINIC RECEPTORS BY ENDOGENOUS ACETYLCHOLINE AND CHOLINESTERASE-INHIBITORS
  1982
• (±)[125Iodo]cyanopindolol, a new ligand for β-adrenoceptors: Identification and quantitation of subclasses of β-adrenoceptors in guinea pig
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1981
• Antitumor Activity, Pharmacology, and Toxicity of Ellipticines, Ellipticinium, and 9-Hydroxy Derivatives: Preliminary Clinical Trials of 2-Methyl-9-Hydroxy Ellipticinium (NSC 264-137)
  Published by Springer Nature ,1980
• Interactions between ellipticine and some derivatives and phospholipids in model membranes
  FEBS Letters, 1979
• BINDING OF ANTAGONISTS TO BRAIN MUSCARINIC RECEPTORS
  1978
• Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding.
  Proceedings of the National Academy of Sciences, 1977